Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells

Prostate

Volumn 74, Issue 12, 2014, Pages 1209-1221

  Hahm, Eun Ryeong ^a   Sakao, Kozue ^b   Singh, Shivendra V ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

autophagy; chemoprevention; honokiol; prostate cancer

Indexed keywords

3 METHYLADENINE; ACETYLCYSTEINE; ANTIOXIDANT; CATALASE; CYTOPROTECTIVE AGENT; HONOKIOL; PEGORGOTEIN; POLYETHYLENE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; ELECTRON SPIN RESONANCE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; RNA INTERFERENCE; TRANSMISSION ELECTRON MICROSCOPY; TRYPAN BLUE ASSAY; TUMOR XENOGRAFT;

AUTOPHAGY; CHEMOPREVENTION; HONOKIOL; PROSTATE CANCER;

ANIMALS; AUTOPHAGY; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CYTOPROTECTION; DRUGS, CHINESE HERBAL; HUMANS; LIGNANS; MALE; MICE; MICE, TRANSGENIC; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 84904600025     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22837     Document Type: Article

References (49)

1. Maruyama Y, Kuribara H,. Overview of the pharmacological features of honokiol. CNS Drug Rev 2000; 6 (1): 35-44.
2. Arora S, Singh S, Piazza GA, Contreras CM, Panyam J, Singh AP,. Honokiol: A novel natural agent for cancer prevention and therapy. Curr Mol Med 2012; 12 (10): 1244-1252.
3. Tsai SK, Huang SS, Hong CY,. Myocardial protective effect of honokiol: An active component in Magnolia officinalis. Planta Med 1996; 62 (6): 503-506.
4. Clark AM, El-Feraly FS, Li WS,. Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J Pharm Sci 1981; 70 (8): 951-952.
5. Hamasaki Y, Muro E, Miyanji S, Yamamoto S, Kobayashi I, Sato R, Zaitu M, Matsuo M, Ichimaru T, Tasaki H, Miyazaki S,. Inhibition of leukotriene synthesis by honokiol in rat basophilic leukemia cells. Int Arch Allergy Immunol 1996; 110 (3): 278-281.
6. Teng CM, Chen CC, Ko FN, Lee LG, Huang TF, Chen YP, Hsu HY,. Two antiplatelet agents from Magnolia officinalis. Thromb Res 1988; 50 (6): 757-765.
7. Fried LE, Arbiser JL,. Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 2009; 11 (5): 1139-1148.
8. Hibasami H, Achiwa Y, Katsuzaki H, Imai K, Yoshioka K, Nakanishi K, Ishii Y, Hasegawa M, Komiya T,. Honokiol induces apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med 1998; 2 (6): 671-673.
9. Hirano T, Gotoh M, Oka K,. Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci 1994; 55 (13): 1061-1069.
10. Hahm ER, Arlotti JA, Marynowski SW, Singh SV,. Honokiol, a constituent of oriental medicinal herb Magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 2008; 14 (4): 1248-1257.
11. Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, Chen L, Wei Y,. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur J Obstet Gynecol Reprod Biol 2008; 140 (1): 95-102.
12. Sheu ML, Liu SH, Lan KH,. Honokiol induces calpain-mediated glucose-regulated protein-94 cleavage and apoptosis in human gastric cancer cells and reduces tumor growth. PLoS ONE 2007; 2 (10): e1096.
13. Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW,. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 2007; 109 (7): 1279-1289.
14. Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D,. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res 2012; 14 (1): R35.
15. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, Arbiser JL,. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 2003; 278 (37): 35501-35507.
16. Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X,. Honokiol: A potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 2004; 10 (23): 3459-3463.
17. Guillermo RF, Chilampalli C, Zhang X, Zeman D, Fahmy H, Dwivedi C,. Time and dose-response effects of honokiol on UVB-induced skin cancer development. Drug Discov Ther 2012; 6 (3): 140-146.
18. Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR,. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin Cancer Res 2010; 16 (9): 2571-2579.
19. Ponnurangam S, Mammen JM, Ramalingam S, He Z, Zhang Y, Umar S, Subramaniam D, Anant S,. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol Cancer Ther 2012; 11 (4): 963-972.
20. Surh YJ,. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3 (10): 768-780.
21. 1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther 2007; 6 (10): 2686-2695.
22. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB,. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-κB activation pathway. Mol Cancer Res 2006; 4 (9): 621-633.
23. Park EJ, Min HY, Chung HJ, Hong JY, Kang YJ, Hung TM, Youn UJ, Kim YS, Bae K, Kang SS, Lee SK,. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett 2009; 277 (2): 133-140.
24. Crane C, Panner A, Pieper RO, Arbiser J, Parsa AT,. Honokiol-mediated inhibition of PI3K/mTOR pathway: A potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. J Immunother 2009; 32 (6): 585-592.
25. Lan KL, Lan KH, Sheu ML, Chen MY, Shih YS, Hsu FC, Wang HM, Liu RS, Yen SH,. Honokiol inhibits hypoxia-inducible factor-1 pathway. Int J Radiat Biol 2011; 87 (6): 579-590.
26. Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G,. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. J Cell Physiol 2012; 227 (5): 2184-2195.
27. Yao CJ, Lai GM, Yeh CT, Lai MT, Shih PH, Chao WJ, Whang-Peng J, Chuang SE, Lai TY,. Honokiol eliminates human oral cancer stem-like cells accompanied with suppression of Wnt/β-catenin signaling and apoptosis induction. Evid Based Complement Alternat Med 2013; 2013: 146136.
28. Hahm ER, Karlsson AI, Bonner MY, Arbiser JL, Singh SV,. Honokiol inhibits androgen receptor activity in prostate cancer cells. Prostate 2014; 74 (4): 408-420.
29. Han LL, Xie LP, Li LH, Zhang XW, Zhang RQ, Wang HZ,. Reactive oxygen species production and Bax/Bcl-2 regulation in honokiol-induced apoptosis in human hepatocellular carcinoma SMMC-7721 cells. Environ Toxicol Pharmacol 2009; 28 (1): 97-103.
30. Li L, Ishdorj G, Gibson SB,. Reactive oxygen species regulation of autophagy in cancer: Implications for cancer treatment. Free Radic Biol Med 2012; 53 (7): 1399-1410.
31. Bommareddy A, Hahm ER, Xiao D, Powolny AA, Fisher AL, Jiang Y, Singh SV,. Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res 2009; 69 (8): 3704-3712.
32. Gewirtz DA,. Cytoprotective and nonprotective autophagy in cancer therapy. Autophagy 2013; 9 (9): 1263-1265.
33. Herman-Antosiewicz A, Johnson DE, Singh SV,. Sulforaphane causes autophagy to inhibit release of cytochrome c and apoptosis in human prostate cancer cells. Cancer Res 2006; 66 (11): 5828-5835.
34. Vyas AR, Hahm ER, Arlotti JA, Watkins S, Stolz DB, Desai D, Amin S, Singh SV,. Chemoprevention of prostate cancer by d, l -sulforaphane is augmented by pharmacological inhibition of autophagy. Cancer Res 2013; 73 (19): 5985-5995.
35. Xiao D, Bommareddy A, Kim SH, Sehrawat A, Hahm ER, Singh SV,. Benzyl isothiocyanate causes FoxO1-mediated autophagic death in human breast cancer cells. PLoS ONE 2012; 7 (3): e32597.
36. Watson PA, Ellwood-Yen K, King JC, Wongvipat J, Lebeau MM, Sawyers CL,. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line. Cancer Res 2005; 65 (24): 11565-11571.
37. 2/M arrest and inducing apoptosis. Carcinogenesis 2003; 24 (5): 891-897.
38. Powolny AA, Bommareddy A, Hahm ER, Normolle DP, Beumer JH, Nelson JB, Singh SV,. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J Natl Cancer Inst 2011; 103 (7): 571-584.
39. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ, Singh SV,. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004; 23 (33): 5594-5606.
40. Hahm ER, Moura MB, Kelley EE, Van Houten B, Shiva S, Singh SV,. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS ONE 2011; 6 (8): e23354.
41. Xiao D, Powolny AA, Moura MB, Kelley EE, Bommareddy A, Kim SH, Hahm ER, Normolle D, Van Houten B, Singh SV,. Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J Biol Chem 2010; 285 (34): 26558-26569.
42. Tsai TH, Chou CJ, Cheng FC, Chen CF,. Pharmacokinetics of honokiol after intravenous administration in rats assessed using high-performance liquid chromatography. J Chromatogr B Biomed Appl 1994; 655 (1): 41-45.
43. Hönscheid P, Datta K, Muders MH,. Autophagy: Detection, regulation and its role in cancer and therapy response. Int J Radiat Biol 2014; in press.
44. Li X, Li X, Wang J, Ye Z, Li JC,. Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells. Int J Biol Sci 2012; 8 (6): 901-912.
45. Lin JF, Tsai TF, Liao PC, Lin YH, Lin YC, Chen HE, Chou KY, Hwang TIS,. Benzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition of mTOR signaling. Carcinogenesis 2013; 34 (2): 406-414.
46. Lorin S, Hamaï A, Mehrpour M, Codogno P,. Autophagy regulation and its role in cancer. Semin Cancer Biol 2013; 23 (5): 361-379.
47. Chang KH, Yan MD, Yao CJ, Lin PC, Lai GM,. Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells. Oncol Lett 2013; 6 (5): 1435-1438.
48. Kaushik G, Ramalingam S, Subramaniam D, Rangarajan P, Protti P, Rammamoorthy P, Anant S, Mammen JM,. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells. Am J Surg 2012; 204 (6): 868-873.
49. Steinmann P, Walters DK, Arlt MJ, Banke IJ, Ziegler U, Langsam B, Arbiser JL, Muff R, Born W, Fuchs B,. Antimetastatic activity of honokiol in osteosarcoma. Cancer 2012; 118 (8): 2117-2127.